C. Papadimitriou

616 total citations
16 papers, 513 citations indexed

About

C. Papadimitriou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, C. Papadimitriou has authored 16 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in C. Papadimitriou's work include Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). C. Papadimitriou is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). C. Papadimitriou collaborates with scholars based in Greece, United States and Sweden. C. Papadimitriou's co-authors include Helena Linardou, Evangelos Briasoulis, D. Bafaloukos, Sharon C. Murray, Dimitrios Siagris, Athanasios Tsamandas, M. Christofidou, Alexandra Lekkou, G Theocharis and Konstantinos Thomopoulos and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C. Papadimitriou

15 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Papadimitriou Greece 9 241 203 100 95 85 16 513
Caecilia Sukowati Italy 16 227 0.9× 429 2.1× 222 2.2× 197 2.1× 202 2.4× 47 848
Xiaojun Zhu China 20 227 0.9× 303 1.5× 78 0.8× 144 1.5× 184 2.2× 70 905
Tianxiang Ge China 11 131 0.5× 181 0.9× 57 0.6× 49 0.5× 99 1.2× 13 410
Sedat Karademır Türkiye 16 192 0.8× 253 1.2× 137 1.4× 84 0.9× 105 1.2× 43 731
Yuchong Peng China 14 218 0.9× 398 2.0× 147 1.5× 125 1.3× 192 2.3× 38 730
Takaaki Mizushima Japan 15 288 1.2× 328 1.6× 114 1.1× 135 1.4× 111 1.3× 34 886
Sabine Strommer Austria 18 213 0.9× 432 2.1× 30 0.3× 80 0.8× 123 1.4× 25 769
Jane Birtwistle United Kingdom 12 65 0.3× 209 1.0× 117 1.2× 102 1.1× 66 0.8× 21 554
Songlin Peng China 7 213 0.9× 250 1.2× 48 0.5× 50 0.5× 146 1.7× 17 507

Countries citing papers authored by C. Papadimitriou

Since Specialization
Citations

This map shows the geographic impact of C. Papadimitriou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Papadimitriou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Papadimitriou more than expected).

Fields of papers citing papers by C. Papadimitriou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Papadimitriou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Papadimitriou. The network helps show where C. Papadimitriou may publish in the future.

Co-authorship network of co-authors of C. Papadimitriou

This figure shows the co-authorship network connecting the top 25 collaborators of C. Papadimitriou. A scholar is included among the top collaborators of C. Papadimitriou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Papadimitriou. C. Papadimitriou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Papadimitriou, C., et al.. (2023). Egg White and Yolk Protein Atlas: New Protein Insights of a Global Landmark Food. Foods. 12(18). 3470–3470. 15 indexed citations
2.
Kouloulias, Vassilis, et al.. (2019). Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy. Clinical & Translational Oncology. 22(4). 447–456. 6 indexed citations
3.
Carlsson, Göran, Tormod Kyrre Guren, Johan Haux, et al.. (2018). ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer. Annals of Oncology. 29. viii190–viii190. 1 indexed citations
4.
Michalaki, Vasiliki, et al.. (2016). P-013 Prognostic significance of cyclin D1 and p21 (WAF1/CIP1) in Gastric Cancer. Annals of Oncology. 27. ii4–ii4.
5.
Thomakos, Nikolaos, Dimitrios Haidopoulos, Maria Sotiropoulou, et al.. (2015). Accuracy of frozen section in the diagnosis of mucinous ovarian tumors. Gynecologic Oncology. 137. 109–109. 1 indexed citations
6.
Terpos, Evangelos, D. Christoulas, Efstathios Kastritis, et al.. (2013). VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT. Leukemia. 28(4). 928–934. 29 indexed citations
7.
Murray, Sharon C., Evangelos Briasoulis, Helena Linardou, D. Bafaloukos, & C. Papadimitriou. (2012). Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies. Cancer Treatment Reviews. 38(7). 890–903. 214 indexed citations
8.
Ihnen, Maike, Ralph M. Wirtz, Konstantine T. Kalogeras, et al.. (2010). Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer. British Journal of Cancer. 103(7). 1048–1056. 18 indexed citations
9.
Kalofonos, Haralabos P., Pavlos Papakostas, Gerasimos Aravantinos, et al.. (2006). A randomised phase II study comparing irinotecan (IRI) plus leucovorin (LV) and 5-fluorouracil (5FU) versus IRI-LV-5FU followed be oxaliplatin (OXA) plus LV-5FU in patients with previously untreated metastatic colorectal cancer (CRC). Journal of Clinical Oncology. 24(18_suppl). 3583–3583. 1 indexed citations
10.
Siagris, Dimitrios, M. Christofidou, G Theocharis, et al.. (2005). Serum lipid pattern in chronic hepatitis C: histological and virological correlations. Journal of Viral Hepatitis. 13(1). 56–61. 117 indexed citations
11.
Bafaloukos, Dimitrios, C. Papadimitriou, Helena Linardou, et al.. (2004). Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group. British Journal of Cancer. 91(9). 1639–1644. 12 indexed citations
12.
Kapranos, Nikiforos, George P. Stathopoulos, Leonidas Manolopoulos, et al.. (2001). p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.. PubMed. 21(1B). 521–8. 59 indexed citations
13.
Fountzilas, George, George P. Stathopoulos, C. Nicolaides, et al.. (1999). Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group. Annals of Oncology. 10(4). 475–478. 16 indexed citations
14.
Dimopoulos, Meletios Α., et al.. (1997). Docetaxel and cisplatin (DC) combination chemotherapy for metastatic urothelial cancer. European Journal of Cancer. 33. S35–S35. 3 indexed citations
15.
Georgoulias, Vassilis, C. Kourousis, N. Androulakis, et al.. (1997). Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.. PubMed. 24(4 Suppl 14). S14–22. 18 indexed citations
16.
Papadimitriou, C., et al.. (1994). Postoperative alkaline reflux gastritis following vagotomy.. PubMed. 41(6). 542–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caecilia Sukowati Breakdown of academic impact, for papers by Xiaojun Zhu Breakdown of academic impact, for papers by Tianxiang Ge Breakdown of academic impact, for papers by Sedat Karademır Breakdown of academic impact, for papers by Yuchong Peng Breakdown of academic impact, for papers by Takaaki Mizushima Breakdown of academic impact, for papers by Sabine Strommer Breakdown of academic impact, for papers by Jane Birtwistle Breakdown of academic impact, for papers by Songlin Peng
Rankless by CCL
2026